Health Care Providers Kit
Downloads
Health Care Provider Kit PDF download
PHS Guidelines for Smoking Cessation
Select Excerpts from the Guidelines:
Benefits of Telephone Care for Smoking Cessation
Who should receive pharmacotherapy for smoking
cessation? Clinical Use of Pharmacotherapies
All smokers trying to quit except in the presence of special circumstances. Special consideration should be given before using pharmacotherapy with selected populations: those with medical contraindications, those smoking less than 10 cigarettes/day, pregnant, and adolescent smokers.
What are the first-line pharmacotherapies recommended in this guideline?
All five of the FDA-approved pharmacotherapies for smoking cessation are
recommended including bupropion SR, nicotine gum, nicotine inhaler, nicotine
nasal spray, and the nicotine patch. Because of the lack of sufficient data to rank-order these five medications, choice of a specific first-line pharmacotherapy must be guided by factors such as clinician familiarity with the medications, contraindications for selected patients, patient preference, previous patient experience with a specific pharmacotherapy (positive or negative), and patient characteristics (e.g., history of depression, concerns about weight gain). If pharmacotherapy is used with lighter smokers, clinicians should consider reducing the dose of first-line pharmacotherapies.
Feel free to contact the cessation center for more information